For Indian vaccine makers, a lot hinges on the WTO
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
$99 for one year
Not ready to subscribe? Sign up for a free account
We value our free readers. Read 100+ stories every year.
More in Business
You may also like
How Bewakoof, once a trendsetter, fell out of favour with young people
Indian youngsters are experimenting with newer D2C brands like never before. Bewakoof’s early success and its 2022 acquisition by retail giant Aditya Birla Fashion should have given it the edge, but the company has been left behind.
Why Nifty 50’s profit is the lowest since COVID-19 pandemic
The earnings of India’s oil refiners and other Nifty 50 companies have taken a hit. But IPO premiums suggest that investors seem unfazed.
Why the current mpox surge has WHO worried
The global health body has declared the latest outbreak a public health emergency of international concern as the rising cases are linked to more virulent strain of the virus.
